2024-02-25 08:49:31 ET
Summary
- NeuroPace shares have doubled since September 2023, driven by strong operating momentum.
- The company aims to improve the lives of epilepsy patients with its remote monitoring system, which has the potential for significant growth.
- Following the share price rally, I have trimmed my position but continue to hold a long position due to the company's potential and operating momentum.
Shares of NeuroPace ( NPCE ) , a relatively smaller epilepsy player, have seen a strong rally towards the end of 2023 and early into 2024. In fact, shares have doubled since I called shares a speculative epilepsy play in September of last year....
Read the full article on Seeking Alpha
For further details see:
NeuroPace: Picking Up The Pace